Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implications.


Journal

European heart journal
ISSN: 1522-9645
Titre abrégé: Eur Heart J
Pays: England
ID NLM: 8006263

Informations de publication

Date de publication:
07 07 2022
Historique:
received: 10 05 2021
revised: 13 03 2022
accepted: 07 04 2022
pubmed: 6 5 2022
medline: 9 7 2022
entrez: 5 5 2022
Statut: ppublish

Résumé

Non-invasive imaging is routinely used to estimate left ventricular (LV) filling pressure (LVFP) in heart failure (HF). Cardiovascular magnetic resonance (CMR) is emerging as an important imaging tool for sub-phenotyping HF. However, currently, LVFP cannot be estimated from CMR. This study sought to investigate (i) if CMR can estimate LVFP in patients with suspected HF and (ii) if CMR-modelled LVFP has prognostic power. Suspected HF patients underwent right heart catheterization (RHC), CMR and transthoracic echocardiography (TTE) (validation cohort only) within 24 h of each other. Right heart catheterization measured pulmonary capillary wedge pressure (PCWP) was used as a reference for LVFP. At follow-up, death was considered as the primary endpoint. We enrolled 835 patients (mean age: 65 ± 13 years, 40% male). In the derivation cohort (n = 708, 85%), two CMR metrics were associated with RHC PCWP:LV mass and left atrial volume. When applied to the validation cohort (n = 127, 15%), the correlation coefficient between RHC PCWP and CMR-modelled PCWP was 0.55 (95% confidence interval: 0.41-0.66, P < 0.0001). Cardiovascular magnetic resonance-modelled PCWP was superior to TTE in classifying patients as normal or raised filling pressures (76 vs. 25%). Cardiovascular magnetic resonance-modelled PCWP was associated with an increased risk of death (hazard ratio: 1.77, P < 0.001). At Kaplan-Meier analysis, CMR-modelled PCWP was comparable to RHC PCWP (≥15 mmHg) to predict survival at 7-year follow-up (35 vs. 37%, χ2 = 0.41, P  = 0.52). A physiological CMR model can estimate LVFP in patients with suspected HF. In addition, CMR-modelled LVFP has a prognostic role.

Identifiants

pubmed: 35512290
pii: 6576529
doi: 10.1093/eurheartj/ehac207
pmc: PMC9259376
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2511-2522

Subventions

Organisme : Wellcome Trust
ID : 220703/Z/20/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M008894/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 215799/Z/19/Z
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/14/6/31350
Pays : United Kingdom
Organisme : Department of Health
ID : NIHR-RP-R3-12-027
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
ESC Heart Fail. 2021 Feb;8(1):566-576
pubmed: 33230957
Circ Res. 1962 Aug;11:315-8
pubmed: 14467155
Arq Bras Cardiol. 2017;108(6):552-563
pubmed: 28562831
Ann Intern Med. 1991 Mar 1;114(5):345-52
pubmed: 1825164
Eur Heart J Cardiovasc Imaging. 2017 Sep 01;18(9):961-968
pubmed: 28444160
J Cardiovasc Magn Reson. 2018 Aug 30;20(1):61
pubmed: 30165869
Br J Anaesth. 1988;60(8 Suppl 1):85S-89S
pubmed: 3284571
Echo Res Pract. 2020 Dec;7(4):G59-G93
pubmed: 33112828
Circulation. 1976 Oct;54(4):662-71
pubmed: 786501
Int J Cardiol. 2021 Aug 1;336:105-112
pubmed: 34044022
J Am Heart Assoc. 2021 Sep 21;10(18):e021165
pubmed: 34476984
J Am Soc Echocardiogr. 2016 Apr;29(4):277-314
pubmed: 27037982
Heart. 2021 May;107(9):697-704
pubmed: 33402364
Circulation. 2006 Aug 15;114(7):654-61
pubmed: 16894035
J Am Coll Cardiol. 2016 Apr 19;67(15):1815-1825
pubmed: 27081022
Circ Heart Fail. 2014 Nov;7(6):935-44
pubmed: 25286913
Am J Cardiol. 2008 Nov 1;102(9):1131-5
pubmed: 18940278
Magn Reson Imaging. 2021 Feb;76:116-122
pubmed: 33221422
Sci Rep. 2020 Jun 18;10(1):9908
pubmed: 32555252
JACC Cardiovasc Imaging. 2010 Apr;3(4):409-20
pubmed: 20394903
J Cardiovasc Magn Reson. 2016 Nov 30;18(1):89
pubmed: 27899132
Eur J Echocardiogr. 2004 Aug;5(4):262-71
pubmed: 15219541
Eur Respir Rev. 2015 Dec;24(138):642-52
pubmed: 26621978
JACC Heart Fail. 2017 Nov;5(11):795-801
pubmed: 29032138
J Cardiovasc Magn Reson. 2019 Oct 7;21(1):61
pubmed: 31590664
Heart. 2002 Apr;87(4):336-9
pubmed: 11907005
Circulation. 2017 Feb 28;135(9):825-838
pubmed: 28039229
Sci Rep. 2018 Sep 26;8(1):14436
pubmed: 30258186
J Thorac Cardiovasc Surg. 2010 Oct;140(4):807-15
pubmed: 20117802
J Cardiovasc Magn Reson. 2020 Feb 24;22(1):17
pubmed: 32089132
J Cardiovasc Magn Reson. 2018 Jan 11;20(1):4
pubmed: 29321034
Eur Heart J. 2014 Nov 21;35(44):3103-12
pubmed: 25161181
Int J Cardiovasc Imaging. 2021 Oct;37(10):3019-3025
pubmed: 33978936
J Am Soc Echocardiogr. 2018 Jan;31(1):79-88
pubmed: 29111121
J Am Coll Cardiol. 2017 Apr 18;69(15):1937-1948
pubmed: 28408024
JACC Cardiovasc Imaging. 2013 Oct;6(10):1036-1047
pubmed: 23769494
Heart Rhythm. 2011 Aug;8(8):1177-82
pubmed: 21376836
Eur Heart J Cardiovasc Imaging. 2022 Jan 24;23(2):e34-e61
pubmed: 34729586
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71
pubmed: 23684677
J Cardiovasc Dev Dis. 2020 Sep 10;7(3):
pubmed: 32927744
Lancet. 2018 Feb 10;391(10120):572-580
pubmed: 29174292
J Am Coll Cardiol. 2014 Mar 25;63(11):1112-8
pubmed: 24518490
Sci Rep. 2021 Jan 12;11(1):617
pubmed: 33436786
Circulation. 2020 Jan 14;141(2):115-123
pubmed: 31865771

Auteurs

Pankaj Garg (P)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
Norwich Medical School, University of East Anglia, Norwich, UK.
Norfolk and Norwich University Hospitals NHS Foundation Trust, Norwich, UK.

Rebecca Gosling (R)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.

Peter Swoboda (P)

The Institute of Cardiovascular and Metabolic Medicine, University of Leeds, UK.

Rachel Jones (R)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.

Alexander Rothman (A)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.

Jim M Wild (JM)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.

David G Kiely (DG)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.
Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Robin Condliffe (R)

Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.

Samer Alabed (S)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.

Andrew J Swift (AJ)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH